As part of the project, a research and development centre will be created in the company “Biomed-Lublin” Wytwórnia Surowic i Vaccine S.A. to improve the technologies related to vaccinology in the prevention of tuberculosis and immunology in the treatment of cancer. The applicant wishes to continuously develop its activities related to the development and marketing of innovative products, which is why it is essential to carry out research and development that will enable it to respond to the identified market demand and to introduce new products to the company’s offer. The purpose of the creation of CBR “Biomed-Lublin” Wytwórnia Surowic and Vaccines S.A. and the implementation of the research agenda is to implement on the market products characterised by international innovation and responding to the needs of customers: a significantly improved BCG vaccine and, first of all, a significantly improved and then a new Onko BCG.